MIST Multimodal Survival Prediction via Genomic-Guided Attention
September 21, 2026
MIST improves survival prediction by using genomic features as tokens to query histology context tokens from foundation models. This approach outperforms standard fusion baselines across colon, renal, lung, and glioblastoma cohorts using discrete-time survival prediction and contrastive alignment.
HOW THIS AFFECTS YOU
●
researcherYou can leverage the genomic-guided histology attention mechanism for improved multimodal fusion in pathology.
●
healthThis could improve prognostic accuracy for oncology patients using existing imaging and genomic data.